Table 3 The laboratory examination of patients with PSIL
| Â | DLBCL | indolent BCL | p value | DLBCL | TCL | p value |
|---|---|---|---|---|---|---|
WBC | 5.0(3.8–6.3) | 4.2(3.8–5.5) | 0.365 | 5.0(3.8–6.3) | 6.4(4.6–7.4) | 0.230 |
Hgb | 102.0(93.0–119.3) | 107.0(84.3–129.5) | 0.847 | 102.0(93.0–119.3) | 115.0(100.0–140.0) | 0.331 |
PLT | 259.0(229.8–292.8) | 201.0(162.3–290.5) | 0.116 | 259.0(229.8–292.8) | 238.0(190.5–318.5) | 0.882 |
NEU | 67.5(60.3–74.4) | 65.2(48.8–75.3) | 0.401 | 67.5(60.3–74.4) | 67.6(58.6–75.4) | 0.882 |
LYM | 20.6(13.6–23.8) | 23.1(15.5–38.1) | 0.270 | 20.6(13.6–23.8) | 17.0(10.5–27.4) | 0.412 |
MONO | 8.2(6.8–11.4) | 7.6(6.1–12.9) | 0.699 | 8.2(6.8–11.4) | 9.9(7.8–14.2) | 0.175 |
CRP | 7.0(5.4–42.2) | 0.8(0.1–3.9) | 0.004 | 7.0(5.4–42.2) | 11.5(3.7–73.2) | 0.456 |
ESR | 13.0(6.0–39.5) | 9.0(2.3–19.0) | 0.515 | 13.0(6.0–39.5) | 35.0(10.5–43.5) | 0.315 |
ALB | 34.1(32.9–35.3) | 40.8(38.1–44.0) | 0.116 | 34.1(32.9–35.3) | 39.5(32.2–41.5) | 0.941 |
LDH | 256.5(201.5–525.0) | 180.5(166.8–213.5) | 0.006 | 256.5(201.5–525.0) | 185.0(155.0–255.0) | 0.113 |
β2- microglobulin | 2334.5(2124.0–2597.5) | 1615.0(1177.5–2465.0) | 0.556 | 2334.5(2124.0–2597.5) | 3120.0(2034.5–3905.0) | 0.730 |
Cr | 78.5(55.8–90.8) | 79.8(57.0–88.1) | 0.847 | 78.5(55.8–90.8) | 76.8(59.9–117.4) | 0.603 |
UA | 285.5(199.0–363.0) | 223.5(189.0–268.5) | 0.949 | 285.5(199.0–363.0) | 285.0(180.0–335.5) | 0.824 |
FIB | 3.8(3.1–5.1) | 2.8(2.4–3.9) | 0.006 | 3.8(3.1–5.1) | 2.9(2.4–4.9) | 0.710 |
D-Dimer | 612.0(372.8–1063.5) | 294.0(222.0–545.3) | 0.002 | 612.0(372.8–1063.5) | 2000.0(529.5–4263.5) | 0.370 |
CEA | 1.7(0.8–1.9) | 1.4(0.8–1.9) | 0.605 | 1.7(0.8–1.9) | 2.2(1.5–2.6) | 0.035 |
CA125 | 19.6(14.0–34.6) | 12.3(7.0–19.0) | 0.300 | 19.6(14.0–34.6) | 25.7(23.1–63.3) | 0.035 |
TSPOT(+ , %) | 2 (28.6) | 3 (33.3) | 1.000 | 2 (28.6) | 0 (0.0) | 0.175 |
CMV (+ , %) | 0 (0.0) | 0 (0.0) | — | 0 (0.0) | 0 (0.0) | — |
EBV (+ , %) | 1 (20.0) | 2 (22.2) | 1.000 | 1 (20.0) | 3 (60.0) | 0.524 |